These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9315990)

  • 1. Clonazepam in the treatment of panic disorder with or without agoraphobia: a dose-response study of efficacy, safety, and discontinuance. Clonazepam Panic Disorder Dose-Response Study Group.
    Rosenbaum JF; Moroz G; Bowden CL
    J Clin Psychopharmacol; 1997 Oct; 17(5):390-400. PubMed ID: 9315990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy, safety, and gradual discontinuation of clonazepam in panic disorder: a placebo-controlled, multicenter study using optimized dosages.
    Moroz G; Rosenbaum JF
    J Clin Psychiatry; 1999 Sep; 60(9):604-12. PubMed ID: 10520979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind clonazepam vs placebo in panic disorder treatment.
    Valença AM; Nardi AE; Nascimento I; Mezzasalma MA; Lopes FL; Zin W
    Arq Neuropsiquiatr; 2000 Dec; 58(4):1025-9. PubMed ID: 11105068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
    Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B
    Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A fixed-dose study of alprazolam 2 mg, alprazolam 6 mg, and placebo in panic disorder.
    Lydiard RB; Lesser IM; Ballenger JC; Rubin RT; Laraia M; DuPont R
    J Clin Psychopharmacol; 1992 Apr; 12(2):96-103. PubMed ID: 1573046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind acute clonazepam vs. placebo in carbon dioxide-induced panic attacks.
    Nardi AE; Valença AM; Nascimento I; Mezzasalma MA; Zin WA
    Psychiatry Res; 2000 May; 94(2):179-84. PubMed ID: 10808043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic response to benzodiazepine in panic disorder subtypes.
    Valença AM; Nardi AE; Mezzasalma MA; Nascimento I; Zin WA; Lopes FL; Versiani M
    Sao Paulo Med J; 2003 Mar; 121(2):77-80. PubMed ID: 12870055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adinazolam-SR in panic disorder with agoraphobia: relationship of daily dose to efficacy.
    Carter CS; Fawcett J; Hertzman M; Papp LA; Jones W; Patterson WM; Swinson RP; Weise CC; Maddock RJ; Denahan AQ
    J Clin Psychiatry; 1995 May; 56(5):202-10. PubMed ID: 7737960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sertraline treatment of panic disorder: results of a long-term study.
    Rapaport MH; Wolkow R; Rubin A; Hackett E; Pollack M; Ota KY
    Acta Psychiatr Scand; 2001 Oct; 104(4):289-98. PubMed ID: 11722304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imipramine treatment of panic disorder with agoraphobia: dose ranging and plasma level-response relationships.
    Mavissakalian MR; Perel JM
    Am J Psychiatry; 1995 May; 152(5):673-82. PubMed ID: 7726306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychopharmacotherapy of panic disorder: 8-week randomized trial with clonazepam and paroxetine.
    Nardi AE; Valença AM; Freire RC; Mochcovitch MD; Amrein R; Sardinha A; Levitan MN; Nascimento I; de-Melo-Neto VL; King AL; de O E Silva AC; Veras AB; Dias GP; Soares-Filho GL; da Costa RT; Mezzasalma MA; de Carvalho MR; de Cerqueira AC; Hallak JE; Crippa JA; Versiani M
    Braz J Med Biol Res; 2011 Apr; 44(4):366-73. PubMed ID: 21344132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and side-effects of alprazolam. Controlled study in agoraphobia with panic disorder.
    O'Sullivan GH; Noshirvani H; Başoğlu M; Marks IM; Swinson R; Kuch K; Kirby M
    Br J Psychiatry; 1994 Jul; 165(1):79-86. PubMed ID: 7802851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discontinuation reactions to alprazolam in panic disorder.
    Pecknold JC
    J Psychiatr Res; 1993; 27 Suppl 1():155-70. PubMed ID: 8145176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do antidepressants selectively suppress spontaneous (unexpected) panic attacks? A replication.
    Uhlenhuth EH; Matuzas W; Warner TD; Paine S; Lydiard RB; Pollack MH
    J Clin Psychopharmacol; 2000 Dec; 20(6):622-7. PubMed ID: 11106133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonazepam in the treatment of panic disorder: a double-blind, placebo-controlled trial investigating the correlation between clonazepam concentrations in plasma and clinical response.
    Beauclair L; Fontaine R; Annable L; Holobow N; Chouinard G
    J Clin Psychopharmacol; 1994 Apr; 14(2):111-8. PubMed ID: 8195451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A controlled, prospective, 1-year trial of citalopram in the treatment of panic disorder.
    Lepola UM; Wade AG; Leinonen EV; Koponen HJ; Frazer J; Sjödin I; Penttinen JT; Pedersen T; Lehto HJ
    J Clin Psychiatry; 1998 Oct; 59(10):528-34. PubMed ID: 9818634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind, placebo-controlled study of a once-a-day, sustained-release preparation of alprazolam for the treatment of panic disorder.
    Schweizer E; Patterson W; Rickels K; Rosenthal M
    Am J Psychiatry; 1993 Aug; 150(8):1210-5. PubMed ID: 8328566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder.
    Ballenger JC; Wheadon DE; Steiner M; Bushnell W; Gergel IP
    Am J Psychiatry; 1998 Jan; 155(1):36-42. PubMed ID: 9433336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind placebo-controlled trial comparing fluvoxamine and imipramine in the treatment of panic disorder with or without agoraphobia.
    Bakish D; Hooper CL; Filteau MJ; Charbonneau Y; Fraser G; West DL; Thibaudeau C; Raine D
    Psychopharmacol Bull; 1996; 32(1):135-41. PubMed ID: 8927663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tapering clonazepam in patients with panic disorder after at least 3 years of treatment.
    Nardi AE; Freire RC; Valença AM; Amrein R; de Cerqueira AC; Lopes FL; Nascimento I; Mezzasalma MA; Veras AB; Sardinha A; de Carvalho MR; da Costa RT; Levitan MN; de-Melo-Neto VL; Soares-Filho GL; Versiani M
    J Clin Psychopharmacol; 2010 Jun; 30(3):290-3. PubMed ID: 20473065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.